Catalyst Wire Dossier Catalyst Wire Dossier

PEP-CMV vaccine

CMV antigen-targeted vaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PEP-CMV vaccine, covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma [Phase 2]

See pricing